From classic to modern prognostic biomarkers in patients with acute myocardial infarction

C Stătescu, L Anghel, BS Tudurachi, A Leonte… - International Journal of …, 2022 - mdpi.com
Despite all the important advances in its diagnosis and treatment, acute myocardial
infarction (AMI) is still one of the most prominent causes of morbidity and mortality …

The role of endocan in cardiometabolic disorders

A Klisic, D Patoulias - Metabolites, 2023 - mdpi.com
Discovered two decades ago, endocan still represents an intriguing biomarker related to
inflammation. Endocan is a soluble dermatan sulphate proteoglycan secreted by endothelial …

Association between serum galectin-3 levels and coronary stenosis severity in patients with coronary artery disease

M Li, K Guo, X Huang, L Feng, Y Yuan, J Li… - Frontiers in …, 2022 - frontiersin.org
Background The relationship between galectin-3 (Gal-3) and coronary artery disease (CAD)
has not been fully elucidated. Aim This study aimed to determine the relationship between …

Relationship between the fibrinogen/albumin ratio and microvascular perfusion in patients undergoing primary percutaneous coronary intervention for ST-elevated …

M Kaplangoray, K Toprak, OF Cicek… - Arquivos Brasileiros de …, 2023 - SciELO Brasil
Background: Correct TIMI frame count (CTFC), myocardial blush grade (MBG), and ST-
segment resolution (STR) are parameters used to evaluate reperfusion at the microvascular …

Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease

I Bošnjak, D Bedeković, K Selthofer-Relatić… - BMC Cardiovascular …, 2023 - Springer
Background This study aimed to investigate the possible role of serum galectin-3 (Gal-3)
levels in the diagnosis and assessment of significant epicardial artery lesions in patients …

Serum endocan levels predict angiographic no-reflow phenomenon in patients with ST-segment elevation myocardial infarction undergoing primary coronary …

M Dogdus, M Yenercag, M Ozyasar, A Yilmaz… - …, 2021 - journals.sagepub.com
No-reflow phenomenon (NRP) is an important problem in patients with ST-segment
elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary …

Relação entre a Relação Fibrinogênio/Albumina ea Perfusão Microvascular em Pacientes Submetidos à Intervenção Coronária Percutânea Primária para Infarto do …

M Kaplangoray, K Toprak, OF Cicek… - Arquivos Brasileiros de …, 2023 - SciELO Brasil
Fundamento A contagem corrigida de quadros TIMI (CTFC), o grau de blush miocárdico
(MBG) ea resolução do segmento ST (STR) são parâmetros utilizados para avaliar a …

急性心肌梗死患者PCI 延时与无延时应用比伐芦定的对照研究

李雪冬, 胡业梅, 王真, 吴纲, 李君, 武永元, 商卓 - 中华全科医学, 2022 - zhqkyx.net
目的评价急性心肌梗死(AMI) 患者接受经皮冠状动脉介入治疗(PCI) 时无延时比伐芦定联合仅冠
脉内替罗非班方案的疗效和安全性. 方法选取2020 年4 月—2021 年3 月蚌埠市第二人民医院心 …

Reply to the letter to the editor:[Comment on “The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation …

M Süleymanoğlu, İ Rencüzoğulları, Y Karabağ… - … International Journal of …, 2021 - Springer
We have read with a great pleasure the letter of Dr. Cure et al. to the editor about our recent
study which showed an association between atherogenic index of plasma (AIP) and no …

Correlation between coronary artery disease and Galectin 3 serum level: Angiographic based study

AM Osman, AM Algamal, AM Elshal… - Ain Shams Medical …, 2024 - asmj.journals.ekb.eg
Background: Galectin 3 (Gal-3) has great impact on initiation and progression of
atherosclerosis as a cardiovascular inflammatory marker. The role of Gal-3 in coronary …